The treatment of Cadmium Toxicity & Varicose Veins with vitamins

Cadmium Toxicity and Varicose Veins: Mitamins custom make quality formulas for the treatment of Cadmium Toxicity & Varicose Veins with vitamins. A Cadmium Toxicity & Varicose Veins formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cadmium Toxicity and Varicose Veins

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin E
    200
    IU
    667%
    Calcium
    200
    mg
    20%
    Magnesium
    100
    mg
    25%
    Zinc
    20
    mg
    133%
    Copper
    1
    mg
    50%
    Lecithin
    100
    mg
    *
  • Amount Per Serving
    % DV
    Bilberry Extract
    50
    mg
    *
    Garlic Extract
    100
    mg
    *
    L-Lysine
    250
    mg
    *
    L-Methionine
    250
    mg
    *
    Butcher's Broom Extract
    50
    mg
    *
    Horse Chestnut Extract
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cadmium Toxicity and Varicose Veins
Serving Size:4-5

Cadmium Toxicity and Varicose Veins Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Keys To How Humans Learn May Be In The Genes
New research is giving scientists fresh insights into how genetics are a prime factor in how we learn.Michael Frank, an assistant professor of psychology and director of the Laboratory for Neural Computation and Cognition at The University of Arizona, headed a team whose results are reported in the Oct. 1 issue of Early Edition, an online site hosted by the Proceedings of the National Academy of Sciences.
Osteoporosis Drug Evista Approved to Cut Risk of Breast Cancer (HealthDay)
The Eli Lilly drug Evista (raloxifene) has been approved by the U.S. Food and Drug Administration to reduce the risk of invasive breast cancer among postmenopausal at high risk for the disease and among postmenopausal women with osteoporosis.
This information concerning the support of Cadmium Toxicity and Varicose Veins treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments